A New Threat to Pregnancy: Xylazine
Xylazine, a veterinary sedative, has become an increasingly common adulterant in the illicit opioid supply, posing unique risks to pregnant individuals and their developing fetuses.
Does Prenatal Cannabis Exposure Affect Executive Function in Preschool-Aged Children?
Prenatal cannabis exposure was associated with deficits in executive function and aggressive behavior; however, there are other important exposures to consider in this study.
Clinical Update 2024: Gabapentin (Neurontin) and Pregnancy
In this study with over 4000 infants exposed to gabapentin, the information is reassuring. While we cannot rule out the possibility of a small increase in risk of cardiovascular malformations in gabapentin-exposed infants, gabapentin does not appear to be a major teratogen.Â
Improving Cognitive Function After Surgical Menopause: A Randomized Controlled Trial of Lisdexamfetamine
The psychostimulant lisdexamfetamine was well-tolerated and improved both subjective and objective measures of attention and working memory in women undergoing surgical menopause.
Ketamine and Pregnancy: Taking a Look at the Practices of Ketamine Clinics
With ketamine and esketamine increasingly used to treat depression, especially in women of reproductive age, this study reveals important gaps in care, including inconsistencies in pregnancy testing, informed consent, and contraception practices among ketamine clinics in the United States.Â
Weekly Roundup for October 4, 2024: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
During Pregnancy: Buprenorphine or Buprenorphine Plus Naloxone?
In this large observational study, similar and, in some instances, more favorable neonatal and maternal outcomes were observed in pregnancies exposed to buprenorphine combined with naloxone compared to pregnancies exposed to buprenorphine alone.
Bridging the Gap: Addressing Ethnic and Racial Inequities in Perinatal Depression Treatment
This study provides valuable insight into the inequities in perinatal mental healthcare and suggests that the most significant barriers to mental healthcare may occur at the provider referral level.
Is it Safe for Breastfeeding Mothers to Use Benzodiazepines?
Clinically significant anxiety symptoms are common during the postpartum period and frequently complicate the treatment of postpartum depression.  While SSRIs are indicted for the treatment anxiety symptoms, especially when they co-occur with depression, many women may need to use a benzodiazepine for managing more severe symptoms of anxiety or insomnia.Â
Your Patient Has Postpartum Depression: Do You Use Zuranolone or a Traditional Antidepressant?
A study using indirect comparisons suggests that zuranolone is more effective than the SSRIs for the treatment of PPD. Should it be the first choice for treatment?